Johann Roessler

Johann Roessler

Auto-generated profile, based on publicly available information

Johann Roessler

Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany (P.R.R., V.N., L.R., J.R., E.A., R.S., U.L., A.H.).

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JRJohann Roessler
Johann Roessler
FZFriederike Zimmermann
Friederike Zimmermann
PSPaul Schumann
Paul Schumann
VNVanasa Nageswaran
Vanasa Nageswaran
PRPegah Ramezani Rad
Pegah Ramezani Rad
AHArash Haghikia
Arash Haghikia
(1) Background: Dyslipidemia represents a major risk factor for atherosclerosis-driven cardiovascular disease. Emerging evidence suggests a close relationship between cholesterol metabolism and gut microbiota. Recently, we demonstrated that the short-chain fatty acid (SCFA) propionate (PA) reduces serum cholesterol levels through an immunomodulatory mechanism. Here, we investigated the effects of oral PA supplementation on the human serum metabolome and analyzed changes in the serum metabolome in relation to the cholesterol-lowering properties of PA. (2) Methods: The serum metabolome of patients supplemented with either placebo or propionate orally for 8 weeks was assessed using a combination of flow injection analysis-tandem (FIA-MS/MS) as well as liquid chromatography (LC-MS/MS) and mass spectrometry using a targeted metabolomics kit (MxP®Quant 500 kit: BIOCRATES Life Sciences AG, Innsbruck, Austria). A total of 431 metabolites were employed for further investigation in this study. (3) Results: We observed a significant increase in distinct bile acids (GCDCA: fold change = 1.41, DCA: fold change = 1.39, GUDCA: fold change = 1.51) following PA supplementation over the study period, with the secondary bile acid DCA displaying a significant negative correlation with the serum cholesterol levels. (4) Conclusions: Oral supplementation with PA modulates the serum metabolome with a particular impact on the circulatory bile acid profile. Since cholesterol and bile acid metabolism are interconnected, the elevation of the secondary bile acid DCA may contribute to the cholesterol-lowering effect of PA.

8 November 2024 in Circulation Research
Verified
Journal Article
Open access
PRPegah Ramezani Rad
Pegah Ramezani Rad
VNVanasa Nageswaran
Vanasa Nageswaran
LPLisa Peters
Lisa Peters
LRLeander Reinshagen
Leander Reinshagen
JRJohann Roessler
Johann Roessler
AHArash Haghikia
Arash Haghikia